Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
14 Sep - 4 Oct 1979
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: This study was selected as the key study because the information provided for the hazard endpoint includes information at concentrations above the limit for classification.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1980
Report date:
1980

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 403 (Acute Inhalation Toxicity)
Deviations:
yes
Remarks:
only males were used
Principles of method if other than guideline:
Ten male rats were exposed to the test substance for a 4-hour exposure period at concentrations of 84000, 121000, 152000, 169000, or 205000 ppm. Clinical signs and body weights were evaluated during the 14-day recovery period. Necropsies were performed on surviving rats after the 14-day recovery period.
GLP compliance:
not specified
Test type:
traditional method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Dimethyl ether
EC Number:
204-065-8
EC Name:
Dimethyl ether
Cas Number:
115-10-6
Molecular formula:
C2H6O
IUPAC Name:
dimethyl ether
Details on test material:
- Physical state: DME is a gas which was received as a liquid under pressure
- Purity: 99.9%

Test animals

Species:
rat
Strain:
other: albino ChR-CD
Sex:
male
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation: 7-8 weeks
- Weight at study initiation: 204-301 g
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: rats were kept for a 10d quarantine period prior to selection for the test

Administration / exposure

Route of administration:
inhalation: gas
Type of inhalation exposure:
whole body
Vehicle:
air
Remark on MMAD/GSD:
Not applicable as DME is a gas.
Details on inhalation exposure:
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure chamber volume: 20 L glass exposure chamber.
- Method of holding animals in test chamber: chamber volume was kept as small as was practical, handling of rats was minimized
- Atmosphere generation: Atmospheres were generated by means of a single stage regulator through a flow meter (with a stainless steel float) directly into the top of a 20-L glass exposure chamber. Dilution air flowing through a flow meter (with a stainless steel float) joined the DME stream at the top of the chamber. The air/DME flow was maintained at 10 L/min.

TEST ATMOSPHERE
- Brief description of analytical method used: GC

Analytical verification of test atmosphere concentrations:
yes
Duration of exposure:
4 h
Concentrations:
8.4; 12.1; 15.2; 16.9; 20.5% (84000; 121000; 152000; 169000; 205000 ppm)
No. of animals per sex per dose:
10 males per concentration; 2 males per cage
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: daily
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight
Statistics:
probit analysis

Results and discussion

Effect levels
Sex:
male
Dose descriptor:
LC50
Effect level:
164 000 ppm
Based on:
test mat.
95% CL:
142 000 - 203 000
Exp. duration:
4 h
Mortality:
Mortality of 0/10, 3/10, 2/10, 7/10, and 7/10 occurred in the 84000, 121000, 152000, 169000, and 205000 ppm groups, respectively. All but one death (205000 ppm) occurred during the exposures.
84000 ppm: ataxia, anesthesia in 2 hours, shallow respiration, lung noise (post exposure); >84000 ppm: ataxia, anesthesia in 15-30 min, heavy respiration, coma, lung noise (post exposure)
Clinical signs:
other: Clinical observations for the 4 highest test concentration groups were similar. Anesthesia was achieved more rapidly at the higher concentrations. Observations were: ataxia, unresponsiveness to noise, anesthesia in 15 to 30 min with heavy respirations
Body weight:
Slight body weight loss 1-2 days post-exposure in the 4 highest test concentration groups
Other findings:
Post-exposure survivors rapidly awoke and showed no clinical signs, other than transient weight loss for 1-2 days and sporadic lung noise. All but 1/19 deaths occurred during the exposure.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
4-hour LC50 = 164000 ppm
The study and the conclusions which are drawn from it fulfil the quality criteria (validity, reliability, repeatability).
Executive summary:

A 4-hour whole-body inhalation LC50 study was conducted in male ChR-CD® rats. During exposure, the rats demonstrated ataxia, anesthesia, coma, and death. Post-exposure, survivors rapidly awoke and showed no clinical signs other than transient weight loss for 1-2 days and sporadic lung noise. All but 1/19 deaths occurred during the exposures. The 4-h LC50 in male ChR-CD® rats is 16.4% (164000 ppm or 309 mg/L) with 95% confidence limits of 14.2 and 20.3%.